triciribine has been researched along with Cancer of Ovary in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sun, H; Zhang, HY; Zhang, PN | 1 |
Cheng, JQ; Coppola, D; He, L; Kong, W; Kruk, PA; Nicosia, SV; O'Donnell, JD; Wang, J; Wenham, RM; Yang, H; Zhao, JJ | 1 |
2 other study(ies) available for triciribine and Cancer of Ovary
Article | Year |
---|---|
Aberration of the PI3K/AKT/mTOR signaling in epithelial ovarian cancer and its implication in cisplatin-based chemotherapy.
Topics: Cell Line, Tumor; Chemotherapy, Adjuvant; Cisplatin; Down-Regulation; Female; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Protein Kinases; Proto-Oncogene Proteins c-akt; Ribonucleosides; Signal Transduction; TOR Serine-Threonine Kinases | 2009 |
MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN.
Topics: Antineoplastic Agents; Apoptosis; Base Sequence; Cell Survival; Cisplatin; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Molecular Sequence Data; Oligonucleotide Array Sequence Analysis; Oncogene Protein v-akt; Ovarian Neoplasms; PTEN Phosphohydrolase; Ribonucleosides; Sequence Homology, Nucleic Acid; Signal Transduction; Tumor Cells, Cultured | 2008 |